Fabino Enterprises Ltd vs Natco Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Fabino Enterprises Ltd is ₹ 20.31 as of 27 Apr 15:30 . The P/E Ratio of Fabino Enterprises Ltd changed from 600 on March 2023 to 84.5 on March 2025 . This represents a CAGR of -47.97% over 3 yearsThe P/E Ratio of Natco Pharma Ltd changed from 34.2 on March 2021 to 7.6 on March 2025 . This represents a CAGR of -25.98% over 5 years The Market Cap of Fabino Enterprises Ltd changed from ₹ 6.3 crore on March 2023 to ₹ 5.15 crore on March 2025 . This represents a CAGR of -6.50% over 3 yearsThe Market Cap of Natco Pharma Ltd changed from ₹ 15045 crore on March 2021 to ₹ 14287 crore on March 2025 . This represents a CAGR of -1.03% over 5 years The revenue of Fabino Enterprises Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Natco Pharma Ltd for the Dec '25 is ₹ 705.4 crore as compare to the Sep '25 revenue of ₹ 1463 crore. This represent the decline of -51.78% The ebitda of Fabino Enterprises Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Natco Pharma Ltd for the Dec '25 is ₹ 216.8 crore as compare to the Sep '25 ebitda of ₹ 679.2 crore. This represent the decline of -68.08% The net profit of Fabino Enterprises Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Natco Pharma Ltd changed from ₹ 668.5 crore to ₹ 140.4 crore over 7 quarters. This represents a CAGR of -59.01% The Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Natco Pharma Ltd changed from 30.96 % on March 2021 to 5.8 % on March 2025 . This represents a CAGR of -28.46% over 5 years .

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

About Natco Pharma Ltd

Natco Pharma Ltd Share Price Overview Natco Pharma Ltd share price history highlights how the stock has evolved across different market cycles.
It reflects both company-specific developments and broader trends in the healthcare sector.
As a participant in this sector, the Natco Pharma Ltd share price movement is often influenced by factors such as drug regulations, generic demand, and changes in investor sentiment. Tracking its historical performance helps investors understand how the Natco Pharma share price has responded to earnings growth, economic shifts, and key business milestones over time. Long-Term Performance The Natco Pharma share price history has shown strong growth over different years.
Over the last five years, Natco Pharma Ltd share has delivered a CAGR of approximately 33.3%. The Natco share price reflects an upward trend, with a period of short-term volatility linked to earnings-related cycles, sector-specific factors, and broader market-sentiment shifts. Impact of Corporate Actions on Natco Pharma Ltd Share Price When analysing Natco Pharma Ltd share price history, it is important to account for corporate actions such as stock splits, bonus issues, and dividend payouts.
These events can adjust the Natco Pharma share price without affecting the company’s underlying value. Using adjusted historical prices provides a more accurate representation of long-term performance and investor returns. Factors Influencing Natco Pharma Ltd Share The following are the factors that may influence the Natco Pharma Ltd share price: Earnings Performance: Fluctuations in earnings due to variations in sales performance, margin, and generic approvals may affect the Natco Pharma share price directly. Order Book and Deal Wins: New order bookings and timely deal executions may have an effect on Natco Pharma Ltd share price performance. Healthcare Sector Growth: Increased demand in generics and policy support can help the Natco Pharma share price grow significantly. International Demand: International demand, especially in oncology drugs, may have a positive effect on Natco Pharma Ltd share revenues. Input Costs: Variations in input costs, like APIs and chemicals, may have an effect on Natco Pharma share profits. Currency Movement: Exchange rate changes may impact Natco Pharma Ltd share price through export revenues and input costs. Market Sentiment: Broader market trends, investor confidence and perception about the company can affect Natco Pharma share price behaviour. Why Check Share Price History of Natco Pharma Ltd Share? Here’s why reviewing the Natco Pharma Ltd share price history can be useful: Understanding Long-Term Trends: Historical data shows how the Natco Pharma share price has moved across different market cycles. Understanding Volatility: Past Natco Pharma Ltd share price movements provide an idea of how the stock behaves during market fluctuations. Comparison with Peers: Comparing performance with other healthcare companies can provide additional clarity. Support Investment Decisions: Reviewing past patterns helps in forming a more balanced and informed perspective. How to Analyse Share Price History of Natco Pharma Ltd Share? To analyse the Natco Pharma share history, individuals can follow the steps given below: Start With the Trend: Check whether the Natco Pharma share price has generally moved upward or experienced phases of consolidation and correction. Identify Support and Resistance: Observe price levels where the share price has previously stopped falling ‘support’ or faced selling pressure ‘resistance’. Analyse Volume: Check whether price movements are supported by higher trading volumes because stronger volume can indicate improved market participation. Utilise Technical Analysis Tools: Simple technical analysis tools, such as the moving average, can help one determine the trend direction and momentum of the Natco Pharma Ltd share price. Track Key Developments: Monitor earnings announcements, deal wins, and news to connect Natco Pharma share price changes with business events. Check Multiple Timeframes: Considering both short and long-term charts may help individuals provide more clarity and understanding of Natco Pharma Ltd share price movements. .

FAQs for the comparison of Fabino Enterprises Ltd and Natco Pharma Ltd

Which company has a larger market capitalization, Fabino Enterprises Ltd or Natco Pharma Ltd?

Market cap of Fabino Enterprises Ltd is 4 Cr while Market cap of Natco Pharma Ltd is 20,672 Cr

What are the key factors driving the stock performance of Fabino Enterprises Ltd and Natco Pharma Ltd?

The stock performance of Fabino Enterprises Ltd and Natco Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fabino Enterprises Ltd and Natco Pharma Ltd?

As of May 7, 2026, the Fabino Enterprises Ltd stock price is INR ₹20.31. On the other hand, Natco Pharma Ltd stock price is INR ₹1154.2.

How do dividend payouts of Fabino Enterprises Ltd and Natco Pharma Ltd compare?

To compare the dividend payouts of Fabino Enterprises Ltd and Natco Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.